Nuvation Bio Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
NUVB, NUVB-WT on NYSE
Industry
Pharmaceutical Preparations
Location
357 Tehama Street, Floor 3, San Francisco, California

Insiders trading volume in the past year

Nuvation Bio Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Omega Fund V, L.P. 10%+ Owner $115 M Apr 5, 2022
Xiangmin Cui Director $20.6 M +$2.32 M +12.6% Jun 25, 2024
Oleg Nodelman Director $17.3 M +$6.69 M +63.4% Sep 19, 2023
Junyuan Jerry Wang CEO, ANHEART THERAPEUTICS LTD., Director $2.63 M Apr 9, 2024
Daniel G. Welch Director $1.08 M May 24, 2024
Kim D. Blickenstaff Director $500 K +$500 K Jun 11, 2024
Moses Makunje Title: VP, Finance and principal financial and accounting officer. $340 K Feb 29, 2024
Colleen Sjogren Chief Commercial Officer $34 K Apr 9, 2024
David C. Hanley Chief Technical Operations $16.3 K Feb 29, 2024
Stacy Markel Chief People Officer $14.4 K Feb 29, 2024
Dongfang Liu Chief Medical Officer $8.17 K Feb 29, 2024
Jennifer Fox Chief Financial Officer $6.1 K Feb 28, 2023
Vernon W Anthony Director May 15, 2023
Robert Mashal Director Jan 8, 2024
Kathryn E. Falberg Director May 15, 2023
Kerry Wentworth Chief Regulatory Officer Feb 29, 2024
Hung David PRESIDENT AND CEO, Director, 10%+ Owner Feb 29, 2024
Robert B. Bazemore Director May 15, 2023
Gary Hattersley Chief Scientific Officer Feb 29, 2024

Recent Insider Transactions by Companies or Individuals for Nuvation Bio Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership